Partial agonism improves the anti-hyperglycaemic efficacy of an oxyntomodulin-derived GLP-1R/GCGR co-agonist. (2021)

First Author: Pickford P
Attributed to:  Developmental Clinical Studies - Curing Obesity with the 'Medical Bypass' funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/j.molmet.2021.101242

PubMed Identifier: 33933675

Publication URI: http://europepmc.org/abstract/MED/33933675

Type: Journal Article/Review

Volume: 51

Parent Publication: Molecular metabolism

ISSN: 2212-8778